Study aimed at establishment of clinical diagnostic criteria and guideline by using a multicenter registry of patients with IgG4-related disease

Study aimed at establishment of clinical diagnostic criteria and guideline by using a multicenter registry of patients with IgG4-related disease - Registry-based study in IgG4 -related disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036532

Enrollment

9999

Registered

2019-07-27

Start date

2019-11-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgG4-related disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as definite, probable and possible IgG4-related disease according to comprehensive diagnostic criteria. 2. Patients who agree about informed consent concerning this study.

Exclusion criteria

Exclusion criteria: 1. Patients in whom similar disease (cancer, Sjogren's syndrome, primary sclerosing cholangitis, Castleman's disease, secondary retroperitoneal fibrosis, Wegener's granulomatosis, sarcoidosis, Churg-Strauss syndrome) cannot be ruled out. 2. Patients who be regarded as inadequate subjects by researchers.

Design outcomes

Primary

Measure	Time frame
Rate of mortality, relapse, and cancer development in IgG4-related disease.	—

Countries

Japan

Contacts

Public ContactIchiro Mizushima

Kanazawa University Hospital Department of Nephrology and Rheumatology

igg4rd@kanazawa-med.ac.jp076-265-2253

Outcome results